Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Darya Khantakova"'
Publikováno v:
Vaccines, Vol 10, Iss 6, p 943 (2022)
Tumor-associated macrophages (TAMs) represent a key component of the tumor microenvironment and are generally associated with immunosuppression and poor prognosis. TREM2 is a transmembrane receptor of the immunoglobulin superfamily expressed in myelo
Externí odkaz:
https://doaj.org/article/e7764fed5fd34ab7b27addfd8ed5f58a
Autor:
Darya Khantakova, Martina Molgora, Julie Roda, Geoffrey Stone, Susan Gilfillan, Tihana Trsan, Marina Cella, Alan Kutach, Daniel Kaplan, Jer-Yuan Hsu, Marco Colonna
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::551230c5ddf8f1eadb7f27d3572a29a0
https://doi.org/10.1136/jitc-2022-sitc2022.0833
https://doi.org/10.1136/jitc-2022-sitc2022.0833
Autor:
Martina Molgora, Blanda Di Luccia, Darya Khantakova, Natalia Jaeger, Rafael Sanguinetti Czepielewski, Cristiane Secca da Silva, Jennifer Bando, Susan Gilfillan, Marina Cella, Robert Schreiber, Marco Colonna
Publikováno v:
Cancer Research. 82:3615-3615
Checkpoint immunotherapy unleashes T cell control of tumors, but is undermined by immunosuppressive myeloid cells. TREM2 is a myeloid receptor that transmits intracellular signals that sustain microglial responses during Alzheimer’s disease. TREM2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::806265f9eb9f91eb461c8134d597fb4d
https://doi.org/10.1158/1538-7445.am2022-3615
https://doi.org/10.1158/1538-7445.am2022-3615
Publikováno v:
Vaccines. 10:943
Tumor-associated macrophages (TAMs) represent a key component of the tumor microenvironment and are generally associated with immunosuppression and poor prognosis. TREM2 is a transmembrane receptor of the immunoglobulin superfamily expressed in myelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22dcaf96d5bd0d1f8becec5ded16e7a0
https://doi.org/10.3390/vaccines10060943
https://doi.org/10.3390/vaccines10060943